Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
An Alabama federal judge has remanded a spinal fixation system case filed against Synthes Spine Inc., ruling that the plaintiff asserted viable claims against an in-state sales representative, thereby destroying diversity jurisdiction.
An Arkansas federal judge has ordered the parties in a Biomet M2a Magnum hip implant case to present arguments as to why the case should not be transferred to a more convenient forum pursuant to 28 U.S.C. Section 1404(a).
A federal appeals court has upheld an award of summary judgment to Boehringer Ingelheim Pharmaceuticals Inc. in a Mirapex compulsive gambling case, finding the claims are time-barred under California’s two-year statute of limitations.
Two new lawsuits linking contaminated valsartan-containing drugs with the development of kidney and liver cancer have been filed in California and Massachusetts federal courts against the drug’s manufacturers.
A California man has sued Arthrex Inc., accusing it of misrepresenting the safety and efficacy of its SwiveLock shoulder implant system, and failing to adequately test the device before aggressively marketing it to surgeons.
A Georgia woman has asked a federal judge to reconsider an award of summary judgment to Cook Medical Inc. in a bellwether case involving its Celect IVC filter, arguing that she provided sufficient evidence that the device maker inadequately warned her surgeon of the risks.
Claims asserted against Mentor and Johnson & Johnson in connection with their MemoryGel silicone breast implants are preempted because they seek to impose state law requirements that are different from, or in addition to, those imposed under federal law, a New Jersey state court has ruled.
A Louisiana federal judge has dismissed a cardiac stent action, ruling that the claims are preempted by federal law because the plaintiffs failed to specify any state law claims based on violations of Food and Drug Administration regulations.
A hernia repair patch case is timely because the plaintiff has sufficiently alleged that the device’s manufacturers fraudulently concealed its defective nature from the plaintiff and her doctors, a Rhode Island judge has ruled.
A Pennsylvania federal judge has dismissed two Zostavax injury actions filed by Florida residents, ruling that because the alleged injuries did not occur in Florida and were not related to any contact Merck had with that state, personal jurisdiction is lacking.